Design Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:DSGN) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 390.56 M341.14 M289.64 M252.09 M226.2 M 총 부채 8.43 M13.83 M11.96 M10 M13.7 M 자본금 총액 382.13 M327.31 M277.69 M242.1 M212.5 M 총 부채 및 주주자본 390.56 M341.14 M289.64 M252.09 M226.2 M 총부채 ————— 순부채 —————

뉴스

FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer

AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

Design Therapeutics Stock Wobbles After Rare Genetic Disease Data - Design Therapeutics (NASDAQ:DSGN)

Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript

This Biotech Leader Ran Up As Much As 18% — And Then Lost It All

Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care Stock - BillionToOne (NASDAQ:BLLN), Desi

Design Therapeutics, Inc. (DSGN) Is Up 6.92% in One Week: What You Should Know

Design Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:DSGN) 2026-04-30

Design Therapeutics, Inc. (DSGN) Q1 2026 Earnings Call Prepared Remarks Transcript

제퍼리스, 디자인 테라퓨틱스에 ’매수’ 의견 제시

Jefferies initiates Design Therapeutics stock with buy on drug potential

디자인 테라퓨틱스, RBC 캐피털 목표 주가 상향 조정